Cargando…

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma

BACKGROUND: Checkpoint inhibitors (CPIs) are thought to be effective against cutaneous melanoma in part because of the large burden of somatic mutations (neoantigens) generated from exposure to ultraviolet radiation. However, rare melanoma subtypes arising from acral skin, mucosal surfaces, and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klemen, Nicholas D., Wang, Melinda, Rubinstein, Jill C., Olino, Kelly, Clune, James, Ariyan, Stephan, Cha, Charles, Weiss, Sarah A., Kluger, Harriet M., Sznol, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103823/ https://www.ncbi.nlm.nih.gov/pubmed/32209601 http://dx.doi.org/10.1136/jitc-2019-000341

Ejemplares similares

Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2019)

Case report: Metastatic Merkel cell carcinoma presenting seven years after loco-regional disease resection of primary tumor with interval in-transit and nodal metastases
por: Rusheen, Joshua, et al.
Publicado: (2023)

Predictive accuracy of elevated mitotic rate on lymph node positivity and recurrence in thin melanomas
por: Ly, Catherine L., et al.
Publicado: (2023)

Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally
por: Esposito, Andrew, et al.
Publicado: (2021)

Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
por: Farshidfar, Farshad, et al.
Publicado: (2022)

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
por: Rubinstein, Jill C, et al.
Publicado: (2010)

Author Correction: Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
por: Farshidfar, Farshad, et al.
Publicado: (2022)

Acral Lentiginous Melanoma: Do Surgical Approach and Sentinel Lymph Node Biopsy Matter?
por: Walker, Marc E., et al.
Publicado: (2020)

Malignant Melanoma in Older Adults: Different Patient or Different Disease?
por: Sasson, Daniel C, et al.
Publicado: (2023)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
por: Kluger, Harriet M, et al.
Publicado: (2007)

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
por: Forschner, Andrea, et al.
Publicado: (2020)

Methods of Sentinel Lymph Node Identification in Auricular Melanoma
por: Noorbakhsh, Seth, et al.
Publicado: (2021)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
por: Schilling, Bastian, et al.
Publicado: (2015)

Management of Acral and Mucosal Melanoma: Medical Oncology Perspective
por: Jung, Seungyeon, et al.
Publicado: (2022)

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
por: Bol, Kalijn Fredrike, et al.
Publicado: (2019)

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
por: Gambichler, Thilo, et al.
Publicado: (2017)

Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
por: Mao, Lili, et al.
Publicado: (2021)

The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
por: Ogata, Dai, et al.
Publicado: (2021)

Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
por: Waninger, Jessica J., et al.
Publicado: (2022)

A Variant in a MicroRNA Complementary Site in the 3′UTR of the KIT Oncogene Increases Risk of Acral Melanoma
por: Godshalk, Sirie E., et al.
Publicado: (2010)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review
por: Zheng, Qingyue, et al.
Publicado: (2020)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
por: Koch, Elias A. T., et al.
Publicado: (2022)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020)

The role of imaging and sentinel lymph node biopsy in patients with T3b-T4b melanoma with clinically negative disease
por: Papageorge, Marianna V., et al.
Publicado: (2023)

Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes
por: Wang, Meng, et al.
Publicado: (2022)

Abstract 139: Prognostic Factors In Determining The Recurrence Of Desmoplastic Melanoma
por: Persing, Sarah, et al.
Publicado: (2019)

Advanced acral melanoma
por: Lambert Smith, Franki, et al.
Publicado: (2015)

The genetic evolution of metastatic uveal melanoma
por: Shain, A. Hunter, et al.
Publicado: (2019)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
por: Heppt, Markus V., et al.
Publicado: (2019)

Acral Melanocytic Neoplasms: A Comprehensive Review of Acral Nevus and Acral Melanoma in Asian Perspective
por: Park, Sanghyun, et al.
Publicado: (2022)

Complete spontaneous regression of a metastatic acral melanoma with associated leukoderma
por: Spring, Isobel R., et al.
Publicado: (2017)

Long-Term Survivors with Metastatic Uveal Melanoma
por: Buzzacco, Dominic M, et al.
Publicado: (2012)

Treatment of Metastatic Uveal Melanoma: Systematic Review
por: Rodriguez-Vidal, Cristina, et al.
Publicado: (2020)

Multiregional genetic evolution of metastatic uveal melanoma
por: Rodriguez, Daniel A., et al.
Publicado: (2021)

Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022)

The genetic evolution of acral melanoma
por: Wang, Meng, et al.
Publicado: (2023)

Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability
por: Belzer, Annika, et al.
Publicado: (2023)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
por: Demirci, Hakan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nrbn4tnrcvns532tc8aogan943